A 14-year-old girl undergoes unilateral salpingo-oophorectomy for a stage IB dysgerminoma of the left ovary. Histopathology confirms pure dysgerminoma with no other germ cell elements. The contralateral ovary was inspected intraoperatively and appeared normal. Peritoneal washings were negative. Serum AFP and β-hCG are now normal post-operatively. What is the most appropriate next step in management?

Explanation

## Clinical Context This is a stage IB pure dysgerminoma in a 14-year-old girl with negative peritoneal washings and normal post-operative tumor markers. The key question is whether adjuvant chemotherapy is indicated. ## Dysgerminoma: Prognostication and Chemotherapy Decisions **Key Point:** Stage IA pure dysgerminoma has excellent prognosis (>95% 5-year survival) and does NOT require adjuvant chemotherapy. Stage IB dysgerminoma also has favorable prognosis and chemotherapy is often omitted in selected cases, particularly in young patients with normal post-operative markers. **High-Yield:** Dysgerminoma is the germ cell tumor most sensitive to both chemotherapy AND radiation, but: - **Stage IA dysgerminoma:** Observation alone is standard (no adjuvant therapy needed) - **Stage IB–IC dysgerminoma:** Observation is acceptable if post-operative markers are normal and compliance is assured; some centers give 1–2 cycles of chemotherapy for stage IB - **Stage II–IV dysgerminoma:** Adjuvant chemotherapy is indicated ## Why Observation is Correct for This Patient 1. **Stage IB with negative washings** — limited disease confined to the ovary with capsular involvement or surface involvement 2. **Pure dysgerminoma** — most chemotherapy-sensitive germ cell tumor; if recurrence occurs, it remains highly chemotherapy-responsive 3. **Normal post-operative markers** — indicates complete tumor resection with no occult metastatic disease 4. **Age and fertility** — avoiding unnecessary chemotherapy in a 14-year-old preserves ovarian function and fertility 5. **Excellent prognosis** — stage IB dysgerminoma has >90% 5-year survival with surgery alone ## Surveillance Protocol for Dysgerminoma | Timepoint | Frequency | Components | | --- | --- | --- | | Months 1–12 | Every 3 months | Clinical exam, serum AFP, β-hCG | | Years 2–5 | Every 6 months | Clinical exam, tumor markers | | Year 5+ | Annually | Clinical exam (if no recurrence) | **Clinical Pearl:** Dysgerminoma is exquisitely radiosensitive (LD~50~ ~0.5 Gy), so historically these tumors were treated with pelvic radiation. Modern practice favors chemotherapy over radiation in reproductive-age women to preserve ovarian function. **Mnemonic — Dysgerminoma Chemotherapy Indications (DCI):** - **D**ysgerminoma stage IA → Observation - **C**hemotherapy for stage IB (optional, risk-adapted) or stage II–IV - **I**f recurrence occurs → Chemotherapy is highly effective **Warning:** Do not confuse dysgerminoma (pure germ cell tumor, excellent prognosis) with mixed germ cell tumors or non-dysgerminoma histologies (yolk sac tumor, embryonal carcinoma), which have worse prognosis and require adjuvant chemotherapy even at stage IA.